Pacira BioSciences
PCRX
PCRX
269 hedge funds and large institutions have $1.44B invested in Pacira BioSciences in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 97 increasing their positions, 84 reducing their positions, and 28 closing their positions.
Holders
269
Holders Change
+9
Holders Change %
+3.46%
% of All Funds
3.9%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
37
Increased
97
Reduced
84
Closed
28
Calls
$4.61M
Puts
$15.3M
Net Calls
-$10.6M
Net Calls Change
-$17.5M
Top Buyers
Top Sellers
1 |
VPC
1
Vestal Point Capital
New York
|
$2.34M |
2 |
2
Morgan Stanley
New York
|
$19.6M |
3 |
RCMNY
3
Rubric Capital Management (New York)
New York
|
$0 |
4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$2.79M |
5 |
5
BlackRock
New York
|
$231M |